DEF 14A

Company

KIORA PHARMACEUTICALS INC

Filed

July 21, 2023

Period of Report

August 31, 2023

Accession Number

0001372514-23-000110

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →